Search - tctmd.com

Displaying 941 - 960 of 1065

Sort: Relevancy | Date

News Conference News TCT 2012

TAVR Feasible for Inoperable Patients with Severe Regurgitation Alone

October 31, 2012

News Industry News

First Results from Medtronic Engager™ European Pivotal Trial Demonstrate Positive Outcomes

October 29, 2012

News Conference News TCT 2012

Repositionable Valves Found Safe, Effective in Two Trials

October 24, 2012

News Conference News TCT 2012

Registries Show TAVR Evolution in UK, Internationally

October 24, 2012

Presentation TCT 2012

Endoluminal Sciences: A New Concept for Eliminating Paravalvular Regurgitation

Presenter: Raj Makkar

October 24, 2012

Presentation TCT 2012

A Novel Balloon-Expandable TAVR System for Aortic Regurgitation

Presenter: Jian Ye

October 24, 2012

Presentation TCT 2012

TCT-97. Three-dimensional Echocardiographic Measurements of the Aortic Annulus Predict Paravavular Regurgitation Following Transcatheter Aortic Valve Replacement

Presenter: Rebecca Hahn

October 23, 2012

Presentation TCT 2012

TCT-92. Does Mitral Regurgitation Impact the Outcome of TAVI Procedures? Insights from the FRANCE2 Registry

Presenter: Eric van Belle

October 23, 2012

Presentation TCT 2012

TCT-91. Peri-valvular Aortic Regurgitation in Balloon-expendable and Self-expendable TAVI procedures: Predictors and Impact on Clinical Outcome - Insights from the FRANCE2 Registry

Presenter: Eric van Belle

October 23, 2012

News Industry News

Neovasc's Tiara™ transcatheter mitral valve selected as a best new device concept at TCT 2012 Scientific Symposium

October 23, 2012

News Industry News

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

October 23, 2012

Presentation TCT 2012

Reduces Paravalvular Regurgitation

Presenter: Benoit Daneault

October 22, 2012

Presentation TCT 2012

Paravalvular Regurgitation as a Strong Predictor of Post-TAVR Mortality

Presenter: Susheel Kodali

October 22, 2012

Presentation TCT 2012

Moderate or Severe Mitral Regurgitation and Aortic Stenosis: Surgery or TAVR?

Presenter: John Webb

October 22, 2012

Presentation TCT 2012

3-D Annulus Sizing (using MSCT or 3-D Echo) Is Now the Gold Standard and Helps to Reduce Paravalvular Regurgitation After TAVR

Presenter: Hasan Jilaihawi

October 22, 2012

News Conference News TCT 2012

Review of TAVR Use Offers Significant Advances, Positive Outcomes

October 22, 2012

News Daily News

Studies Show Efficacy, Relative Safety of Valve-in-Valve Technique

L.A. McKeown

October 18, 2012

News Daily News

Blood Transfusion Associated with Acute Kidney Injury in TAVR Patients

Caitlin E. Cox

October 15, 2012

News Industry News

First Patient Enrolled in REPRISE II TAVR Clinical Trial to Evaluate the Safety and Performance of the Lotus™ Valve System

October 10, 2012

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

Advertisement

TAVR Feasible for Inoperable Patients with Severe Regurgitation Alone

First Results from Medtronic Engager™ European Pivotal Trial Demonstrate Positive Outcomes

Repositionable Valves Found Safe, Effective in Two Trials

Registries Show TAVR Evolution in UK, Internationally

Endoluminal Sciences: A New Concept for Eliminating Paravalvular Regurgitation

A Novel Balloon-Expandable TAVR System for Aortic Regurgitation

TCT-97. Three-dimensional Echocardiographic Measurements of the Aortic Annulus Predict Paravavular Regurgitation Following Transcatheter Aortic Valve Replacement

TCT-92. Does Mitral Regurgitation Impact the Outcome of TAVI Procedures? Insights from the FRANCE2 Registry

TCT-91. Peri-valvular Aortic Regurgitation in Balloon-expendable and Self-expendable TAVI procedures: Predictors and Impact on Clinical Outcome - Insights from the FRANCE2 Registry

Neovasc's Tiara™ transcatheter mitral valve selected as a best new device concept at TCT 2012 Scientific Symposium

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

Reduces Paravalvular Regurgitation

Paravalvular Regurgitation as a Strong Predictor of Post-TAVR Mortality

Moderate or Severe Mitral Regurgitation and Aortic Stenosis: Surgery or TAVR?

3-D Annulus Sizing (using MSCT or 3-D Echo) Is Now the Gold Standard and Helps to Reduce Paravalvular Regurgitation After TAVR

Review of TAVR Use Offers Significant Advances, Positive Outcomes

Studies Show Efficacy, Relative Safety of Valve-in-Valve Technique

Blood Transfusion Associated with Acute Kidney Injury in TAVR Patients

First Patient Enrolled in REPRISE II TAVR Clinical Trial to Evaluate the Safety and Performance of the Lotus™ Valve System

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content